Clinical use of E-coli Nissle 1917 in inflammatory bowel disease

被引：210

作者：

Schultz, Michael ^{[1
]}

机构：

[1] Univ Otago, Sch Med, Dept Med & Surg Sci, Med Sect, Dunedin, New Zealand

来源：

INFLAMMATORY BOWEL DISEASES | 2008年 / 14卷 / 07期

关键词：

E. coli Nissle 1917; 5-ASA; clinical use; probiotics; inflammatory bowel disease;

D O I：

10.1002/ibd.20377

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The probiotic Escherichia coli strain Nissle 1917 is in addition to some Lactobacilli sp. one of the best-studied probiotic strains. This particular E. coli strain was isolated in 1917 based on its potential to protect from presumably infectious gastroenteritis. Initial therapeutic success was noted in the management of gastrointestinal infectious disorders and infections affecting the urinary tract; the focus shifted later to chronic inflammatory conditions. The unique combination of fitness and survival factors to support intestinal survival, the lack of virulence, and obvious probiotic properties make this microorganism a safe and effective candidate in the treatment of chronic inflammatory bowel diseases. Three large clinical trials have assessed the potential in the maintenance of remission of ulcerative colitis and equivalence to standard 5-ASA medication was documented. This review aims to discuss important mechanisms of E coli Nissle 1917 and will review the available literature regarding treatment of inflammatory bowel diseases.

引用

页码：1012 / 1018

页数：7

共 64 条

[1] High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan
Adlerberth, I
Jalil, F
Carlsson, B
Mellander, L
Hanson, LÅ
Larsson, P
Khalil, K
Wold, AE
[J]. EPIDEMIOLOGY AND INFECTION, 1998, 121 (03) : 587 - 598
[2] The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens
Altenhoefer, A
Oswald, S
Sonnenborn, U
Enders, C
Schulze, J
Hacker, J
Oelschlaeger, TA
[J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 40 (03): : 223 - 229
[3] PROPERTIES OF ESCHERICHIA-COLI STRAINS OF SEROTYPE O6
BLUM, G
MARRE, R
HACKER, J
[J]. INFECTION, 1995, 23 (04) : 234 - 236
[4] Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples
Blum-Oehler, G
Oswald, S
Eiteljörge, K
Sonnenborn, U
Schulze, J
Kruis, W
Hacker, J
[J]. RESEARCH IN MICROBIOLOGY, 2003, 154 (01) : 59 - 66
[5] Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E-coli strains isolated from patients with Crohn's disease
Boudeau, J
Glasser, AL
Julien, S
Colombel, JF
Darfeuille-Michaud, A
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (01) : 45 - 56
[6] ADHESIVE ESCHERICHIA-COLI IN INFLAMMATORY BOWEL-DISEASE AND INFECTIVE DIARRHEA
BURKE, DA
AXON, ATR
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6641): : 102 - 104
[7] Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota
Elson, CO
Cong, Y
McCracken, VJ
Dimmitt, RA
Lorenz, RG
Weaver, CT
[J]. IMMUNOLOGICAL REVIEWS, 2005, 206 : 260 - 276
[8] ESCHERICH T, 1885, FORTSCHR MED, V16, P512
[9] TLRs in the gut. III. Immune responses to flagellin in Crohn's disease: good, bad, or irrelevant?
Gewirtz, Andrew T.
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (03): : G706 - G710
[10] Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways
Grabig, A.
Paclik, D.
Guzy, C.
Dankof, A.
Baumgart, D. C.
Erckenbrecht, J.
Raupach, B.
Sonnenborn, U.
Eckert, J.
Schumann, R. R.
Wiedenmann, B.
Dignass, A. U.
Sturm, A.
[J]. INFECTION AND IMMUNITY, 2006, 74 (07) : 4075 - 4082

← 1 2 3 4 5 6 7 →